Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation of GLP-1 Agonists Following Bariatric Surgery
NCT06132477Phase 4Recruiting
- Sponsor
- University of Missouri
- Start
- Feb 2024
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in obesity and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Missouri. Primary endpoints: Effect of GLP1-RA on weight loss at 6 months, Effect of GLP1-RA on circulating bile acids and metabolites at 6 months and 3 more. Started Feb 2024; status: recruiting.
02
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06132477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06132477.